Federal Circuit Says Licensee Can’t Sue on its Own: USFRF v. FujiFilm Medical
Client Alert | 3 min read | 12.01.21
Last week, the U.S. Court of Appeals for the Federal Circuit publicly released[1] an opinion further clarifying the standard for determining a licensee’s right to sue for patent infringement on its own. See Univ. of S. Florida Rsch. Found., Inc. v. FujiFilm Med. Sys. U.S.A., Inc. In particular, the decision clarifies that if a license does not explicitly transfer the right to sue, the licensee may not have the right to sue on its own. This decision may impact how patent owners structure and phrase their license agreements going forward, particularly in the university research space, where universities often reserve key rights to their licensed patents.
In this case, the inventors assigned all rights in the invention to the University of South Florida (“USF”), which in turn transferred certain rights to the University of South Florida Research Foundation (“USFRF”) through a license agreement. The license agreement stated that “USF and USFRF desire to cooperate in the development, protection, and commercial exploitation of the said invention.” The license was silent on the transfer of the right to sue. This omission was pivotal in the Court’s determination that USFRF lacked the statutory right under 35 U.S.C. § 281 to sue on its own.
The Court explained that a patent owner may transfer all substantial rights in a patent, in which case the transfer is tantamount to an assignment to the licensee, who may then maintain an infringement suit in its own name. While the Federal Circuit has never established a complete list of the rights that must be examined to determine whether the parties intended a transfer of all substantial rights, it reiterated several considerations, including:
- “the nature and scope of the licensor’s retained right to sue accused infringers,” which the Court called “the most important factor in determining whether an exclusive license transfers sufficient rights to render the licensee the owner of the patent”
- “the exclusive right to make, use, and sell”
- “the scope of the licensee’s right to sublicense”
- “the nature of license provisions regarding the reversion of rights to the licensor following breaches of the license agreement”
- “the right of the licensor to receive a portion of the recovery in infringement suits brought by the licensee”
- “the duration of the license rights granted to the licensee”
- “the ability of the licensor to supervise and control the licensee’s activities”
- “the obligation of the licensor to continue paying patent maintenance fees”
- “the nature of any limits on the licensee’s right to assign its interests in the patent”
Here, an important fact was that the license did not explicitly transfer the right to sue for infringement, but instead was silent on that right. The Court held that the agreement’s silence indicated USF’s intent to reserve the right, not to transfer it. The fact that USF and USFRF had agreed to allocate damages between them also weighed against a conclusion that USF transferred all substantial rights. The Court acknowledged that the license transferred “significant rights” to USFRF and that the duration of the license was substantial, but nonetheless held “USF retained enough important rights to conclude that USF did not transfer all substantial rights in the patent.”
The Court did not agree, however, with the district court’s holding that USFRF lacked constitutional standing. On that issue, the Court found that “constitutional standing is satisfied when a party holds at least one exclusionary right” and that USFRF had at least one exclusionary right in the patent at the time it filed suit. The Court remanded for further proceedings, including to determine whether USF may be joined as a party to satisfy the statutory requirement.
This decision provides the relevant framework for analyzing whether all substantial rights are transferred under Federal Circuit law. The decision, therefore, may significantly impact how patent owners, particularly universities, choose to structure and phrase their license agreements going forward. The case reinforces that when a patent owner retains key rights—particularly the exclusive right to make, use, and sell, and rights to enforce the patent against accused infringers—or is silent on those rights, the licensee may lack the statutory right to sue on its own. Each license agreement must, of course, be evaluated based on its specific terms and the intentions of the parties.
[1] The Federal Circuit decided this case in a sealed opinion dated October 22, 2021 and released the public version of the opinion last week.
Insights
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality
On the morning of December 12, 2025, the Eleventh Circuit heard argument in United States ex rel. Zafirov v. Florida Medical Associates, LLC, et al., No. 24-13581 (11th Cir. 2025). This case concerns the constitutionality of the False Claims Act (FCA) qui tam provisions and a groundbreaking September 2024 opinion in which the United States District Court for the Middle District of Florida held that the FCA’s qui tam provisions were unconstitutional under Article II. See United States ex rel. Zafirov v. Fla. Med. Assocs., LLC, 751 F. Supp. 3d 1293 (M.D. Fla. 2024). That decision, penned by District Judge Kathryn Kimball Mizelle, was the first success story for a legal theory that has been gaining steam ever since Justices Thomas, Barrett, and Kavanaugh indicated they would be willing to consider arguments about the constitutionality of the qui tam provisions in U.S. ex rel. Polansky v. Exec. Health Res., 599 U.S. 419 (2023). In her opinion, Judge Mizelle held (1) qui tam relators are officers of the U.S. who must be appointed under the Appointments Clause; and (2) historical practice treating qui tam and similar relators as less than “officers” for constitutional purposes was not enough to save the qui tam provisions from the fundamental Article II infirmity the court identified. That ruling was appealed and, after full briefing, including by the government and a bevy of amici, the litigants stepped up to the plate this morning for oral argument.
Client Alert | 8 min read | 12.11.25
Director Squires Revamps the Workings of the U.S. Patent Office
Client Alert | 8 min read | 12.10.25
Creativity You Can Use: CJEU Clarifies Copyright for Applied Art
Client Alert | 4 min read | 12.10.25
Federal Court Strikes Down Interior Order Suspending Wind Energy Development
